Conceptio
›
multiple-myeloma
Topic
multiple-myeloma
Knowledge-graph topic
· documents ABOUT multiple-myeloma across the archive
675
Documents about multiple-myeloma
Documents about multiple-myeloma
A Study of Subcutaneous Delivery of JNJ-54767414 in Chinese Participants With Multiple Myeloma
#852514
ClinicalTrials.gov
A Real-World Study of Bispecific Antibodies in Multiple Myeloma
#855677
ClinicalTrials.gov
A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma
#880703
ClinicalTrials.gov
Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)
#894034
ClinicalTrials.gov
Detection of Amyloidosis in Multiple Myeloma Patients by [18F]Florbetaben Positron Emission Tomography
#908502
ClinicalTrials.gov
Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma
#911693
ClinicalTrials.gov
Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma
#914611
ClinicalTrials.gov
Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM)
#917709
ClinicalTrials.gov
Japanese Phase 2 Study to Evaluate the Efficacy and Safety of Pomalidomide in Subjects With Relapsed and Refractory Multiple Myeloma
#811750
ClinicalTrials.gov
Allogeneic UCB-derived, Dual-targeting BCMA/CD19 CAR-T for Relapsed/Refractory Multiple Myeloma
#826356
ClinicalTrials.gov
A Clinical Study to Evaluate the Effects of RO7875913 in Healthy Participants and of RO7875913 With Cevostamab in Participnats With With Relapsed/Refractory Multiple Myeloma
#847108
ClinicalTrials.gov
Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)
#874070
ClinicalTrials.gov
High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
#894585
ClinicalTrials.gov
Multiple myeloma hastalarında tanı aldıktan sonra 1. basamak tedavi sırasında gelişen enfeksiyonların retrospektif olarak incelenmesi
#442815
Necmettin Erbakan University Institutional Repository
Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL
#845526
ClinicalTrials.gov
Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
#902655
ClinicalTrials.gov
Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma Patients
#827666
ClinicalTrials.gov
Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma
#856323
ClinicalTrials.gov
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma
#885188
ClinicalTrials.gov
Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma
#893463
ClinicalTrials.gov
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
#296807
Gestión del Repositorio Documental de la Universidad de Salamanca
Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival
#296812
Gestión del Repositorio Documental de la Universidad de Salamanca
A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma
#978915
ClinicalTrials.gov
Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
#18599
ClinicalTrials.gov
Dendritic Cell Vaccine in Treating Patients With Indolent B-Cell Lymphoma or Multiple Myeloma
#390959
ClinicalTrials.gov
Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma
#825336
ClinicalTrials.gov
Teclistamab Expanded Access Treatment Protocol for Relapsed or Refractory Multiple Myeloma Patients
#828149
ClinicalTrials.gov
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
#854915
ClinicalTrials.gov
An Observational Study of Chinese Multiple Myeloma Patients Treated With Velcade
#859680
ClinicalTrials.gov
An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma
#869040
ClinicalTrials.gov
Carfilzomib in Treating Patients With Multiple Myeloma in First Relapse or Refractory to First-Line Therapy
#872989
ClinicalTrials.gov
Clinical Trial of Consolidation Treatment With Iodine I 131 Tositumomab for Multiple Myeloma
#878117
ClinicalTrials.gov
Expanded Access Program for Melphalan Flufenamide (Melflufen) in Triple Class Refractory Multiple Myeloma
#886782
ClinicalTrials.gov
Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma
#902561
ClinicalTrials.gov
A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects
#908656
ClinicalTrials.gov
MGTA-145 + Plerixafor in the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma
#917464
ClinicalTrials.gov
Prevention of Treatment Induced Neuropathy in Multiple Myeloma
#915500
ClinicalTrials.gov
Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy
#915305
ClinicalTrials.gov
Effects of Controlled Breathing on Cardiorespiratory Variables in Multiple Myeloma
#885444
ClinicalTrials.gov
Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation
#907887
ClinicalTrials.gov
Autologous Chimeric Antigen Receptor (CAR) T-cells Targeting the Kappa Myeloma Antigen (KMA) in Kappa Restricted Multiple Myeloma Patients With Relapsed/Refractory Disease
#414505
ClinicalTrials.gov
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
#873892
ClinicalTrials.gov
A Study of the Safety and Pharmacology of SGN-40 Administered in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
#980308
ClinicalTrials.gov
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
#127820
ClinicalTrials.gov
Study of Alternative and Approved Dosing Regimens of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Relapsed/Refractory Multiple Myeloma
#267997
ClinicalTrials.gov
A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)
#346908
ClinicalTrials.gov
Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression
#800657
ClinicalTrials.gov
A Study of the First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Spain
#813443
ClinicalTrials.gov
Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma
#829381
ClinicalTrials.gov
Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma
#837899
ClinicalTrials.gov
← Previous
Page 6 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.